Decibel Therapeutics Inc

NASDAQ:DBTX  
2.35
+0.12 (+5.38%)
Earnings Announcements

Decibel Therapeutics Reports Q1 Financial Results

Published: 05/12/2022 12:01 GMT
Decibel Therapeutics Inc (DBTX) - Decibel Therapeutics Reports First Quarter 2022 Financial Results and Corporate Update.
Decibel - Believes Its Existing Cash, Cash Equivalents & Available-for-sale Securities Will Fund Its Pipeline Programs & Operating Expenses Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.58

More details on our Analysts Page.